| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1969) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6J9BLA949Q |
| InChI Key | BPEWUONYVDABNZ-DZBHQSCQSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H24O3 |
| Molecular Weight | 300.4 |
| AlogP | 3.59 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 43.37 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 22.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Cytochrome P450 19A1 inhibitor | FDA |
| Primary Target | |
|---|---|
| CYP19A1 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 19
Cytochrome P450 family 19A
Cytochrome P450 19A1
|
- | - | - | 35000 | 16-22 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Puberty, Precocious | 2 | D011629 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 968-93-4 |
| ChEBI | 9460 |
| ChEMBL | CHEMBL1571 |
| DrugBank | DB00894 |
| DrugCentral | 2606 |
| EPA CompTox | DTXSID2023644 |
| FDA SRS | 6J9BLA949Q |
| Human Metabolome Database | HMDB0015031 |
| Guide to Pharmacology | 7303 |
| KEGG | C02197 |
| PharmGKB | PA164743056 |
| PubChem | 13769 |
| SureChEMBL | SCHEMBL4053 |
| ZINC | ZINC000004081771 |